Mesenchymal stem cells confer chemoresistance in breast cancer via a CD9 dependent mechanism.
CD9
MSCs
chemoresistance
cytokine
xenograft tumors
Journal
Oncotarget
ISSN: 1949-2553
Titre abrégé: Oncotarget
Pays: United States
ID NLM: 101532965
Informations de publication
Date de publication:
28 May 2019
28 May 2019
Historique:
received:
28
03
2019
accepted:
05
05
2019
entrez:
14
6
2019
pubmed:
14
6
2019
medline:
14
6
2019
Statut:
epublish
Résumé
The development of chemotherapy drug resistance remains a significant barrier for effective therapy in several cancers including breast cancer. Bone marrow-derived mesenchymal stem cells (BMMSCs) have previously been shown to influence tumor progression and the development of chemoresistance. In the present study, we showed that when GFP labelled BMMSCs and RFP labelled HCC1806 cells are injected together
Identifiants
pubmed: 31191817
doi: 10.18632/oncotarget.26952
pii: 26952
pmc: PMC6544397
doi:
Types de publication
Journal Article
Langues
eng
Pagination
3435-3450Déclaration de conflit d'intérêts
CONFLICTS OF INTEREST The authors have no competing financial interests.
Références
Blood. 1999 Mar 1;93(5):1658-67
pubmed: 10029595
Nat Med. 1999 Jun;5(6):662-8
pubmed: 10371505
Cancer Res. 1999 Sep 15;59(18):4681-7
pubmed: 10493525
Biol Pharm Bull. 2000 Aug;23(8):926-9
pubmed: 10963297
Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2397-402
pubmed: 12606728
Blood. 2003 Nov 15;102(10):3837-44
pubmed: 12881305
Exp Mol Pathol. 2003 Dec;75(3):248-55
pubmed: 14611816
J Exp Med. 2006 May 15;203(5):1235-47
pubmed: 16636132
Pflugers Arch. 2007 Nov;455(2):283-96
pubmed: 17668233
Clin Cancer Res. 2007 Sep 1;13(17):5020-7
pubmed: 17785552
Nature. 2007 Oct 4;449(7162):557-63
pubmed: 17914389
Cancer Lett. 2008 Sep 28;269(1):67-77
pubmed: 18571836
PLoS One. 2008 Jun 25;3(6):e2563
pubmed: 18575622
Cancer Res. 2009 Feb 1;69(3):1009-15
pubmed: 19155309
PLoS One. 2009 Jul 17;4(7):e6278
pubmed: 19609435
Mol Cancer. 2010 May 28;9:129
pubmed: 20509882
Exp Cell Res. 2010 Dec 10;316(20):3417-24
pubmed: 20633553
Eur J Cell Biol. 2010 Nov;89(11):843-52
pubmed: 20709424
Cancer Res. 2010 Oct 15;70(20):8025-35
pubmed: 20940407
Stem Cells Dev. 2011 Aug;20(8):1297-308
pubmed: 21303266
Gene Ther. 2011 Jul;18(7):692-701
pubmed: 21368903
Mol Med. 2011;17(7-8):579-87
pubmed: 21424106
PLoS One. 2012;7(4):e35101
pubmed: 22506069
Cancer Res. 2012 Aug 15;72(16):4178-92
pubmed: 22751465
Br Med Bull. 2012 Sep;103(1):129-45
pubmed: 22864058
Cell Mol Immunol. 2013 Jul;10(4):303-10
pubmed: 23376885
Arthritis Rheum. 2013 Jul;65(7):1786-94
pubmed: 23553439
PLoS One. 2013 Apr 17;8(4):e61834
pubmed: 23613949
Cancer Treat Rev. 2013 Dec;39(8):935-46
pubmed: 23643661
Differentiation. 2013 Feb;85(3):78-90
pubmed: 23644554
Stem Cell Res Ther. 2013 Aug 19;4(4):99
pubmed: 23958031
Nat Rev Cancer. 2013 Oct;13(10):714-26
pubmed: 24060863
Oncotarget. 2014 Feb 15;5(3):613-33
pubmed: 24327602
Mediators Inflamm. 2014;2014:292376
pubmed: 24523569
PLoS One. 2014 May 02;9(5):e95765
pubmed: 24788635
Mol Cancer Res. 2014 Dec;12(12):1840-50
pubmed: 25103498
Front Immunol. 2014 Sep 16;5:442
pubmed: 25278937
Sci Rep. 2014 Nov 24;4:7162
pubmed: 25418289
Transl Res. 2015 May;165(5):558-77
pubmed: 25468484
CA Cancer J Clin. 2015 Mar;65(2):87-108
pubmed: 25651787
Oncotarget. 2015 Apr 10;6(10):7970-91
pubmed: 25762645
Stem Cells Dev. 2015 Jul 15;24(14):1635-47
pubmed: 25867197
Cell Cycle. 2015 Aug 3;14(15):2473-83
pubmed: 26091251
Clin Cancer Res. 2016 Jan 15;22(2):395-404
pubmed: 26369630
Breast Cancer (Auckl). 2015 Sep 27;9(Suppl 2):17-34
pubmed: 26462242
J Am Heart Assoc. 2016 Jan 25;5(1):null
pubmed: 26811168
Sci Rep. 2016 Feb 25;6:21961
pubmed: 26911789
Oncotarget. 2016 May 24;7(21):30935-50
pubmed: 27105533
Int J Hematol. 2016 Sep;104(3):281-92
pubmed: 27411688
Toxicol Res. 2016 Jul;32(3):251-8
pubmed: 27437093
Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):E6447-E6456
pubmed: 27698134
Int J Endocrinol. 2016;2016:5286972
pubmed: 27990160
Mol Cancer. 2017 Feb 1;16(1):31
pubmed: 28148268
Sci Rep. 2017 Feb 08;7:42226
pubmed: 28176874
Cell Death Discov. 2017 Feb 06;3:16064
pubmed: 28179988
Stem Cells Transl Med. 2017 Mar;6(3):736-747
pubmed: 28297576
Biosci Rep. 2017 Jul 21;37(4):
pubmed: 28659496
Sci Rep. 2017 Oct 13;7(1):13162
pubmed: 29030596
Mol Ther. 2018 Feb 7;26(2):634-647
pubmed: 29221804
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Nat Rev Clin Oncol. 2018 Apr;15(4):234-248
pubmed: 29405201
Mol Ther Methods Clin Dev. 2018 Mar 29;9:278-287
pubmed: 29707602
Int J Mol Sci. 2018 May 16;19(5):null
pubmed: 29772686
Blood. 1993 Dec 15;82(12):3712-20
pubmed: 8260708